Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
10 participants
OBSERVATIONAL
2004-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486
Genetic Susceptibility to Lung Cancer in Never Smokers
NCT00597636
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
NCT07008664
Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers
NCT01176383
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
NCT02671045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aberrant methylation is an important event in the transcriptional silencing of candidate tumor suppressor genes in smoking associated malignancies. Furthermore, it is known that methylated CpG islands are the preferred binding site for benzo(a)pyrene diol epoxide and other carcinogens found in tobacco smoke. Binding of these compounds is known to cause DNA adducts and transversion mutations that are often observed in the aerodigestive tumors of smokers. New evidence suggests that specific DNA methylation events are directly linked to tobacco use. The ability to detect such molecular markers during screening of high risk groups would represent a significant advance in cancer screening and early detection. Our group has evaluated specimens to epigenetically profile CpG island hypermethylation in. head and neck squamous cell carcinoma ( HNSCC) tumor samples using a technique known as methylation specific restriction enzyme microarray analysis. This method will be used in this trial to detect alterations in global DNA methylation patterns in subjects who smoke compared to those who don't.
The objectives of this study are:
1. Test the hypothesis that there are specific genetic alterations, leading to gene expression profile changes, which will be detected in early smokers.
2. Test the hypothesis that early smokers will demonstrate alterations in global DNA methylation patterns compared to matched controls.
3. To analyze gene alterations and DNA methylation in college smokers over time through longitudinal follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
smokers
college students who smoke
No interventions assigned to this group
non smokers
college students who don't smoke
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Smokers must be between the ages of 18 and 25
Smokers must have smoked regularly for at least 2 years and be currently smoking
Smokers must intend to stay in the New York area for at least 3 years.
Non-smokers must be non-users of marijuana -
Exclusion Criteria
Use of chewing tobacco
\-
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montefiore Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MOntefiore Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard V Smith, MD
Role: STUDY_CHAIR
Montefiore Medical Center
Thomas Belbin, PhD
Role: PRINCIPAL_INVESTIGATOR
Albert Einstein College of Medicine
Nicholas Schlecht, PhD
Role: PRINCIPAL_INVESTIGATOR
Albert Einstein College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical Center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-01-008S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.